Acrospire Investment Management LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 112 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$83,000
-7.8%
7,047
-14.2%
0.08%
+5.4%
Q1 2017$90,000
-62.0%
8,213
-74.8%
0.07%
-24.5%
Q4 2016$237,000
+59.1%
32,629
+42.4%
0.10%
-1.0%
Q3 2016$149,000
+16.4%
22,917
-2.4%
0.10%
+4.2%
Q2 2016$128,000
+88.2%
23,475
+61.9%
0.10%
+102.1%
Q1 2016$68,00014,5010.05%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders